Rathbones Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,450
| Closed | -$201K | – | 631 |
|
|
2024
Q2 | $201K | Buy |
+7,450
| New | +$155K | ﹤0.01% | 549 |
|
|
2023
Q3 | – | Sell |
-7,450
| Closed | -$242K | – | 645 |
|
|
2023
Q2 | $242K | Hold |
7,450
| – | – | ﹤0.01% | 359 |
|
|
2023
Q1 | $292K | Hold |
7,450
| – | – | ﹤0.01% | 346 |
|
|
2022
Q4 | $394K | Hold |
7,450
| – | – | ﹤0.01% | 315 |
|
|
2022
Q3 | $335K | Hold |
7,450
| – | – | ﹤0.01% | 330 |
|
|
2022
Q2 | $271K | Hold |
7,450
| – | – | ﹤0.01% | 362 |
|
|
2022
Q1 | $308K | Hold |
7,450
| – | – | ﹤0.01% | 355 |
|
|
2021
Q4 | $317K | Hold |
7,450
| – | – | ﹤0.01% | 356 |
|
|
2021
Q3 | $410K | Hold |
7,450
| – | – | ﹤0.01% | 324 |
|
|
2021
Q2 | $357K | Hold |
7,450
| – | – | ﹤0.01% | 343 |
|
|
2021
Q1 | $377K | Hold |
7,450
| – | – | ﹤0.01% | 321 |
|
|
2020
Q4 | $469K | Hold |
7,450
| – | – | 0.01% | 290 |
|
|
2020
Q3 | $501K | Sell |
7,450
-300
| -4% | -$16.4K | 0.01% | 259 |
|
|
2020
Q2 | $325K | Buy |
7,750
+260
| +3% | +$9.98K | 0.01% | 282 |
|
|
2020
Q1 | $236K | Hold |
7,490
| – | – | 0.01% | 272 |
|
|
2019
Q4 | $302K | Hold |
7,490
| – | – | 0.01% | 272 |
|
|
2019
Q3 | $244K | Buy |
+7,490
| New | +$298K | 0.01% | 290 |
|
Other funds holding SILK
Rathbones Group's SILK Position: Q3 2024 in Review
Rathbones Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 7,450 shares — an estimated $201K sold.
Rathbones Group first reported a position in SILK in Q3 2019 and held it in 17 quarters. The position peaked at $501K in Q3 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Rathbones Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Rathbones Group sold 7,450 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $201K.
- Rathbones Group first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 17 quarters.
- Rathbones Group's Silk Road Medical, Inc. Common Stock position peaked at $501K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Rathbones Group's 13F filing for Q3 2024, filed 13 Nov 2024.